- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Long term ues of Low-dose aspirin use linked to anaemia among elderly
Australia: A recent study in Annals of Internal Medicine found increased incident anaemia and a decline in ferritin with the use of low-dose aspirin in otherwise healthy older adults, independent of major bleeding.
"Low-dose aspirin was associated with a 20% increased incidence of anaemia and decline in ferritin, or blood iron levels," the researchers reported in the analysis of the ASPREE (ASPirin in Reducing Events in the Elderly) trial. "These findings suggest that periodic haemoglobin monitoring should be considered in older patients taking aspirin."
Approximately half of older persons in the United States have reported preventative aspirin use. One of the complications of aspirin use is an increased risk for major bleeding, particularly gastrointestinal bleeding. Although the risk for overt bleeding due to aspirin has been well characterized, very few studies have measured the effect of aspirin on anaemia, particularly in older populations.
Researchers from Monash University, Melbourne, conducted a post-hoc analysis of the ASPREE randomized controlled trial. The trial included 19,114 persons aged 70 years or older randomly assigned to take 100 mg of aspirin daily or placebo. Haemoglobin was measured annually, and ferritin was measured at baseline and 3 years after randomization. The data showed that the risk for developing anaemia was 23.5 percent among those assigned to receive low-dose aspirin.
These results were accompanied by a small but greater decrease in mean haemoglobin and a greater decline in ferritin concentrations among those receiving aspirin. Differences in clinically significant bleeding events did not account for the overall difference in incident anaemia or the decline in ferritin observed in ASPREE. Still, they were most likely due to occult blood loss, given the observed steeper decline in ferritin in participants allocated to aspirin.
Reference:
Zoe K. McQuilten, Le Thi Phuong Thao, Sant-Rayn Pasricha, Andrew S. Artz, Michael Bailey, Andrew T. Chan, Harvey Jay Cohen, Jessica E. Lockery, Anne M. Murray, Mark R. Nelson, Hans G. Schneider, Rory Wolfe, Robyn L. Woods, Erica M. Wood, John J. McNeil, https://doi.org/10.7326/M23-0675.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751